nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Gadoversetamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Gadoversetamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Gadoversetamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Injury—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Pain—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Gadoversetamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Gadoversetamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.001	0.001	CcSEcCtD
Gadoversetamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000995	0.000995	CcSEcCtD
Gadoversetamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000995	0.000995	CcSEcCtD
Gadoversetamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00099	0.00099	CcSEcCtD
Gadoversetamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00099	0.00099	CcSEcCtD
Gadoversetamide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00099	0.00099	CcSEcCtD
Gadoversetamide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00099	0.00099	CcSEcCtD
Gadoversetamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000987	0.000987	CcSEcCtD
Gadoversetamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000979	0.000979	CcSEcCtD
Gadoversetamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.000978	CcSEcCtD
Gadoversetamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000978	0.000978	CcSEcCtD
Gadoversetamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000975	0.000975	CcSEcCtD
Gadoversetamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000975	0.000975	CcSEcCtD
Gadoversetamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000972	0.000972	CcSEcCtD
Gadoversetamide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00097	0.00097	CcSEcCtD
Gadoversetamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00097	0.00097	CcSEcCtD
Gadoversetamide—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000968	0.000968	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000967	0.000967	CcSEcCtD
Gadoversetamide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00096	0.00096	CcSEcCtD
Gadoversetamide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000955	0.000955	CcSEcCtD
Gadoversetamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00094	0.00094	CcSEcCtD
Gadoversetamide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.000935	CcSEcCtD
Gadoversetamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.000935	CcSEcCtD
Gadoversetamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000923	0.000923	CcSEcCtD
Gadoversetamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.000923	CcSEcCtD
Gadoversetamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000922	0.000922	CcSEcCtD
Gadoversetamide—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000919	0.000919	CcSEcCtD
Gadoversetamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000904	0.000904	CcSEcCtD
Gadoversetamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000899	0.000899	CcSEcCtD
Gadoversetamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000899	0.000899	CcSEcCtD
Gadoversetamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000886	0.000886	CcSEcCtD
Gadoversetamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000886	0.000886	CcSEcCtD
Gadoversetamide—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000885	0.000885	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000885	0.000885	CcSEcCtD
Gadoversetamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00088	0.00088	CcSEcCtD
Gadoversetamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.000871	CcSEcCtD
Gadoversetamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000868	0.000868	CcSEcCtD
Gadoversetamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.000857	CcSEcCtD
Gadoversetamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000857	0.000857	CcSEcCtD
Gadoversetamide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000853	0.000853	CcSEcCtD
Gadoversetamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.000849	CcSEcCtD
Gadoversetamide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000844	0.000844	CcSEcCtD
Gadoversetamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000839	0.000839	CcSEcCtD
Gadoversetamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000837	0.000837	CcSEcCtD
Gadoversetamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000831	0.000831	CcSEcCtD
Gadoversetamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000828	0.000828	CcSEcCtD
Gadoversetamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000828	0.000828	CcSEcCtD
Gadoversetamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000811	0.000811	CcSEcCtD
Gadoversetamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.000809	CcSEcCtD
Gadoversetamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000796	0.000796	CcSEcCtD
Gadoversetamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000796	0.000796	CcSEcCtD
Gadoversetamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00079	0.00079	CcSEcCtD
Gadoversetamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.00079	CcSEcCtD
Gadoversetamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.000789	CcSEcCtD
Gadoversetamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000789	0.000789	CcSEcCtD
Gadoversetamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000785	0.000785	CcSEcCtD
Gadoversetamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000785	0.000785	CcSEcCtD
Gadoversetamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000783	0.000783	CcSEcCtD
Gadoversetamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000782	0.000782	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000782	0.000782	CcSEcCtD
Gadoversetamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00078	0.00078	CcSEcCtD
Gadoversetamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000774	0.000774	CcSEcCtD
Gadoversetamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000773	0.000773	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000771	0.000771	CcSEcCtD
Gadoversetamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000769	0.000769	CcSEcCtD
Gadoversetamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.000752	CcSEcCtD
Gadoversetamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00075	0.00075	CcSEcCtD
Gadoversetamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000747	0.000747	CcSEcCtD
Gadoversetamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.000746	CcSEcCtD
Gadoversetamide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000745	0.000745	CcSEcCtD
Gadoversetamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.000745	CcSEcCtD
Gadoversetamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000744	0.000744	CcSEcCtD
Gadoversetamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000744	0.000744	CcSEcCtD
Gadoversetamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000741	0.000741	CcSEcCtD
Gadoversetamide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000731	0.000731	CcSEcCtD
Gadoversetamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000729	0.000729	CcSEcCtD
Gadoversetamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00072	0.00072	CcSEcCtD
Gadoversetamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000718	0.000718	CcSEcCtD
Gadoversetamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.000702	CcSEcCtD
Gadoversetamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000699	0.000699	CcSEcCtD
Gadoversetamide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000697	0.000697	CcSEcCtD
Gadoversetamide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000694	0.000694	CcSEcCtD
Gadoversetamide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00069	0.00069	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000678	0.000678	CcSEcCtD
Gadoversetamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000678	0.000678	CcSEcCtD
Gadoversetamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000667	0.000667	CcSEcCtD
Gadoversetamide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000662	0.000662	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000656	0.000656	CcSEcCtD
Gadoversetamide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000648	0.000648	CcSEcCtD
Gadoversetamide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000644	0.000644	CcSEcCtD
Gadoversetamide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000629	0.000629	CcSEcCtD
Gadoversetamide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000627	0.000627	CcSEcCtD
Gadoversetamide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00062	0.00062	CcSEcCtD
Gadoversetamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000614	0.000614	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000609	0.000609	CcSEcCtD
Gadoversetamide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000608	0.000608	CcSEcCtD
Gadoversetamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000604	0.000604	CcSEcCtD
Gadoversetamide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000604	0.000604	CcSEcCtD
Gadoversetamide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.00058	CcSEcCtD
Gadoversetamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00056	0.00056	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000555	0.000555	CcSEcCtD
Gadoversetamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000545	0.000545	CcSEcCtD
Gadoversetamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000543	0.000543	CcSEcCtD
Gadoversetamide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000542	0.000542	CcSEcCtD
Gadoversetamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000539	0.000539	CcSEcCtD
Gadoversetamide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000531	0.000531	CcSEcCtD
Gadoversetamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000521	0.000521	CcSEcCtD
Gadoversetamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000514	0.000514	CcSEcCtD
Gadoversetamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000514	0.000514	CcSEcCtD
Gadoversetamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000512	0.000512	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000511	0.000511	CcSEcCtD
Gadoversetamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000508	0.000508	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.0005	0.0005	CcSEcCtD
Gadoversetamide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000493	0.000493	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000493	0.000493	CcSEcCtD
Gadoversetamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000485	0.000485	CcSEcCtD
Gadoversetamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000483	CcSEcCtD
Gadoversetamide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000479	0.000479	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000477	0.000477	CcSEcCtD
Gadoversetamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00047	0.00047	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000449	0.000449	CcSEcCtD
Gadoversetamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.000449	CcSEcCtD
Gadoversetamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000446	0.000446	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000443	0.000443	CcSEcCtD
Gadoversetamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000434	0.000434	CcSEcCtD
Gadoversetamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000428	0.000428	CcSEcCtD
Gadoversetamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.000428	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.000427	CcSEcCtD
Gadoversetamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000422	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000406	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000403	CcSEcCtD
Gadoversetamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.000403	CcSEcCtD
Gadoversetamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000392	0.000392	CcSEcCtD
Gadoversetamide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00039	CcSEcCtD
Gadoversetamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00039	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000363	CcSEcCtD
Gadoversetamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000354	0.000354	CcSEcCtD
Gadoversetamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000349	0.000349	CcSEcCtD
Gadoversetamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000337	CcSEcCtD
Gadoversetamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000326	CcSEcCtD
Gadoversetamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000313	0.000313	CcSEcCtD
Gadoversetamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000311	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000311	CcSEcCtD
Gadoversetamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000309	CcSEcCtD
Gadoversetamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000293	CcSEcCtD
